Not "limit", rather "efficacy":
Once we hit 4000mg, assuming there are no clinical adverse reactions, we could (technically) successfully treat a subject that has sepsis.
I think this will attract widespread attention, as from this point on Recce 327 starts to look less like a risk, and more like an opportunity. i.e. F.O.M.O. will build.
All I.M.O. of course.
- Forums
- ASX - By Stock
- RCE
- Ann: Positive safety data from 4th Cohort -Phase I Clinical Trial
Ann: Positive safety data from 4th Cohort -Phase I Clinical Trial, page-17
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RCE (ASX) to my watchlist
(20min delay)
|
|||||
Last
46.5¢ |
Change
-0.005(1.06%) |
Mkt cap ! $102.0M |
Open | High | Low | Value | Volume |
46.0¢ | 47.0¢ | 46.0¢ | $1.125K | 2.443K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 210845 | 46.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
47.0¢ | 60263 | 7 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
3 | 210845 | 0.460 |
6 | 185159 | 0.455 |
11 | 110829 | 0.450 |
1 | 100000 | 0.445 |
7 | 161417 | 0.440 |
Price($) | Vol. | No. |
---|---|---|
0.470 | 60263 | 7 |
0.475 | 34613 | 3 |
0.480 | 20194 | 4 |
0.485 | 82243 | 1 |
0.490 | 12000 | 1 |
Last trade - 12.44pm 30/07/2024 (20 minute delay) ? |
Featured News
RCE (ASX) Chart |
The Watchlist
MTL
MANTLE MINERALS LIMITED
Nick Poll, Executive Director
Nick Poll
Executive Director
SPONSORED BY The Market Online